MAPLE GROVE, Minn. — Upsher-Smith Laboratories on Wednesday launched Clomipramine Hydrochloride Capsules USP, 25 mg, 50 mg and 75 mg, the generic equivalent to Mallinckrodt Pharmaceuticals’ Anafranil (clomipramine hydrochloride) Capsules USP in the United States.
The clomipramine hydrochloride capsules market had U.S. sales of approximately $172 million for the 12 months ending December 2016, according to IMS Health.
“Upsher-Smith has long been recognized within the pharmaceutical industry as a trusted name in generics,” said Rusty Field, President, Upsher-Smith. “This is an exciting time for the company. Upsher-Smith currently has more active ANDA programs in development than at any point in its history and is committed to expanding its portfolio of quality, high-value generic products through both internal development and strategic partnerships.”
Upsher-Smith Laboratories, founded in 1919, is a fully integrated pharmaceutical company dedicated to its mission of delivering high-value, high-quality therapies and solutions which measurably improve individuals’ lives.